NEVIRAPINE
- Product NDC
- 65862-933
- 11-digit product format
- 658620933
- Labeler code
- 65862
- Product ID
- 65862-933_b707329a-0d1c-47af-a4a1-3289bc6064a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NEVIRAPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA207698
- Marketing category
- ANDA
- Marketing start
- 2017-02-28
- Marketing end
- 0000-00-00
- Substance
- NEVIRAPINE
- Active strength
- 400 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65862-933-05 | 65862093305 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-933-05) | 2017-02-28 | 0000-00-00 | No | No | Current |
| 65862-933-30 | 65862093330 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-933-30) | 2017-02-28 | 0000-00-00 | No | No | Current |
| 65862-933-90 | 65862093390 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-933-90) | 2017-02-28 | 0000-00-00 | No | No | Current |
| 65862-933-99 | 65862093399 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65862-933-99) | 2017-02-28 | 0000-00-00 | No | No | Current |